Proxi Biotech ApS: Financial statements 2025
CVR: 39859211
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Proxi Biotech ApS (CVR 39859211) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -430,820 and a net result of DKK -1,688,504 compared with DKK 426,762 the year before. Equity in the 2025 report amounted to DKK -1,712,625. The company had 2 employees in the financial year.
- Gross Profit
- DKK -430,820
- Profit/Loss
- DKK -1,688,504
- Equity
- DKK -1,712,625
- Total Assets
- DKK 3,048,335
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -431 t. | -1.7 mio. | -1.7 mio. | 2 |
| 2024 | - | 984 t. | 427 t. | 417 t. | 1 |
| 2023 | - | 521 t. | 69 t. | -10 t. | 1 |
| 2022 | - | 411 t. | -72 t. | -79 t. | 1 |
| 2021 | - | 461 t. | 2 t. | -6 t. | 1 |
Official annual report
How creditworthy is Proxi Biotech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of December 19, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Proxi Biotech ApS.
As of December 19, 2025, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of Proxi Biotech ApS.
As of November 10, 2025, Per Bo Pedersen Fischer has joined the board of directors of Proxi Biotech ApS.
As of November 10, 2025, Rene Jørgensen has joined the board of directors of Proxi Biotech ApS.
As of November 10, 2025, Sten Verland has joined the board of directors of Proxi Biotech ApS.
As of November 10, 2025, Aria Aminzadeh has joined the board of directors of Proxi Biotech ApS.
As of November 10, 2025, Paul Jefferson Hargreaves has joined the board of directors of Proxi Biotech ApS.
Proxi Biotech ApS has published its annual report for 2024. Gross profit came to DKK 983,921, and the net result was DKK 426,762.
As of April 9, 2025, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Proxi Biotech ApS.
As of April 9, 2025, JS Revision, Godkendt Revisionsaktieselskab has stepped down as auditor of Proxi Biotech ApS.
About Proxi Biotech ApS
Proxi Biotech ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named PrOxi Biotech ApS and PrOxi Biotech IVS. The management consists of Rene Jørgensen and Aria Aminzadeh. The board consists of Sten Verland (chair), Aria Aminzadeh, Paul Jefferson Hargreaves and Per Bo Pedersen Fischer. The company is owned by Aminzadeh Holding ApS, Dr RJ Holding ApS and Century House Holding ApS. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK -430,820 and a net result of DKK -1,688,504 compared with DKK 426,762 the year before. Equity in the 2025 report amounted to DKK -1,712,625.